Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: ten years of successful antivascular therapy

Lex Eggermont, Timo ten Hagen

Research output: Contribution to journalArticleAcademic

23 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)79-80
Number of pages2
JournalCurrent Oncology Reports
Issue number2
Publication statusPublished - 2003

Research programs

  • EMC MM-03-47-11

Cite this